×
ADVERTISEMENT

ZUMA-2

CAR T-Cell Therapy Extends Survival in Relapsed/Refractory Mantle Cell Lymphoma

ORLANDO, FLA.—In patients with relapsed or refractory mantle cell lymphoma and few remaining treatment ...

FEBRUARY 25, 2020

Load more